April 16, 2020 eyong FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies Previous Post COVID-19: EU recommendations for community measures Next Post FDA, Gates Foundation, UnitedHealth Group, Quantigen, and U.S. Cotton Collaborate to Address Testing Supply Needs
